文献速递炎症性肠病

炎症性肠病单核细胞反应解卷积揭示调控IL-23的IL-1细胞因子网络与遗传及获得性IL-10抵抗

Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance.
PubMed 文献 · Gut · 2020-10-09

研究通过转录组分析和单细胞RNA测序,在健康人和IBD患者中鉴定表达IL-23的单核细胞亚群,发现IL-1α/IL-1β和IL-10是调控IL-23产生单核细胞的关键细胞因子。IL-10受体信号遗传缺陷和全菌暴露诱导的获得性IL-10信号抵抗均可导致IL-23分泌。产IL-23炎性单核细胞的转录特征可预测疾病及抗TNF治疗无应答,并与稳态IL-23相关的淋巴细胞分化特征区分。

要点

  • IL-1α/IL-1β和IL-10是调控单核细胞产生IL-23的关键细胞因子。
  • 产IL-23炎性单核细胞的转录特征可预测IBD疾病及抗TNF治疗无应答。
  • 重度活动性溃疡性克罗恩病和抗TNF无应答患者的过度炎症相关IL-23产生与稳态IL-23产生不同。

核心结论

  • IL-10和IL-1是单核细胞产生IL-23的关键调控因子。
  • 在重度活动性溃疡性克罗恩病和抗TNF治疗无应答患者中,过度炎症相关IL-23产生不同于稳态IL-23产生。
  • 研究识别出可能受益于IL-23p19和/或IL-1α/IL-1β靶向治疗(作用于IL-23上游)的IBD患者亚组。

研究设计与样本

  • 研究对人生单核吞噬细胞和外周血单个核细胞进行转录组分析以探究IL-23表达。
  • 研究探究IL-23表达的调控,并使用单细胞RNA测序得出过度炎症单核细胞的转录特征。
  • 研究使用基因网络相关分析,将患者活检样本中的该特征解卷积为与稳态和炎症相关的组分。

主要发现

  • 研究表征了健康个体和IBD患者中表达IL-23的单核细胞亚群。
  • 研究鉴定出IL-1α/IL-1β的自感知和旁分泌感知以及IL-10是控制产IL-23单核细胞的关键细胞因子。
  • IL-10受体信号孟德尔遗传缺陷在脂多糖刺激后诱导IL-23分泌,而全菌暴露通过获得性IL-10信号抵抗在对照中诱导IL-23产生。
  • 产IL-23炎性单核细胞的转录特征可预测疾病和抗肿瘤坏死因子(TNF)治疗抵抗,并与稳态和疾病中存在的IL-23相关淋巴细胞分化特征区分。

临床怎么用

  • 作者识别出可能受益于IL-23p19和/或IL-1α/IL-1β靶向治疗(作用于IL-23上游)的IBD患者亚组。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Dysregulated immune responses are the cause of IBDs. Studies in mice and humans suggest a central role of interleukin (IL)-23-producing mononuclear phagocytes in disease pathogenesis. Mechanistic insights into the regulation of IL-23 are prerequisite for selective IL-23 targeting therapies as part of personalised medicine. DESIGN: We performed transcriptomic analysis to investigate IL-23 expression in human mononuclear phagocytes and peripheral blood mononuclear cells. We investigated the regulation of IL-23 expression and used single-cell RNA sequencing to derive a transcriptomic signature of hyperinflammatory monocytes. Using gene network correlation analysis, we deconvolved this signature into components associated with homeostasis and inflammation in patient biopsy samples. RESULTS: We characterised monocyte subsets of healthy individuals and patients with IBD that express IL-23. We identified autosensing and paracrine sensing of IL-1α/IL-1β and IL-10 as key cytokines that control IL-23-producing monocytes. Whereas Mendelian genetic defects in IL-10 receptor signalling induced IL-23 secretion after lipopolysaccharide stimulation, whole bacteria exposure induced IL-23 production in controls via acquired IL-10 signalling resistance. We found a transcriptional signature of IL-23-producing inflammatory monocytes that predicted both disease and resistance to antitumour necrosis factor (TNF) therapy and differentiated that from an IL-23-associated lymphocyte differentiation signature that was present in homeostasis and in disease. CONCLUSION: Our work identifies IL-10 and IL-1 as critical regulators of monocyte IL-23 production. We differentiate homeostatic IL-23 production from hyperinflammation-associated IL-23 production in patients with severe ulcerating active Crohn's disease and anti-TNF treatment non-responsiveness. Altogether, we identify subgroups of patients with IBD that might benefit from IL-23p19 and/or IL-1α/IL-1β-targeting therapies upstream of IL-23.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Aschenbrenner D, Quaranta M, Banerjee S, et al. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut. 2020. PMID: 33037057. doi:10.1136/gutjnl-2020-321731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。